NCT01770106View on ClinicalTrials.gov

RA Denosumab on Bone Microstructure Study

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Denosumab

Subcutaneous injection of denosumab 60mg every 6 months (1 dose for study period)

DRUG

Alendronate

Alendronate 70mg once weekly

Trial Locations (1)

Unknown

Prince of Wales Hospital, Shatin

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

NCT01770106 - RA Denosumab on Bone Microstructure Study | Biotech Hunter | Biotech Hunter